Little Falls, NJ, December 07, 2012 --(PR.com
)-- Sentrx, the industry-leader in global pharmacovigilance outsourcing, is pleased to announce the hiring of three professionals to enhance its business development team.
· Craig Hatton, Director, Commercial Solutions Eastern North America, previously worked in business development and sales at Biomedical Systems, Delta Pharma, Liquent Inc. and Thomson Scientific.
· Suzette Sutton, Business Development Technical Engineer, previously employed by BSI Group – Entropy, IntelliSoft Group, Cornell/Columbia New York Presbyterian, and Fidelity Investments.
· Janice Scheider, Business Development Channel Manager, previous work experience includes various positions at Foresight Group International, and Kemper Insurance Companies.
“Adding talent to our Business Development team will pay tremendous dividends to our prospective clients, our current clients and our company,” says Michael O’Gorman, CEO of Sentrx. “Craig, Suzette and Janice bring the experience and personality necessary to build strong relationships with our clients, and will play integral roles in developing valuable solutions for them,” adds O’Gorman. “Our company philosophy begins with a strong client-centric foundation, and the addition of these team members strengthens this foundation.”
Sentrx’s strategic work models and partnerships allows the company to provide professional and qualified service and support to anywhere in the world. In order to expand their scope of business to a widening national and international level and to support recent and future growth, Sentrx also plans to continue hire additional the very best healthcare professionals with specific therapeutic expertise to match customer needs.
Sentrx is a pioneer in pharmacovigilance outsourcing service and is a leading provider of technology-enabled solutions and services for global drug safety. Its mission is to be the best pharmacovigilance outsourcing company in the world. Sentrx helps pharmaceutical, biotechnology, medical device, and consumer health companies document the safety profile of their products during clinical development and post-approval, enabling them to minimize risks and maximize benefits. To learn more about Sentrx, please visit the company's website at http://www.Sentrx.com, or call 973-812-7575.